🇺🇸 FDA
Patent

US 8372979

Process for the production of high-purity 2,4′-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions that contain the latter, as well as active ingredient formulations that contain tolperisone

granted A61KA61K31/4453A61K9/0053

Quick answer

US patent 8372979 (Process for the production of high-purity 2,4′-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions that contain the latter, as well as active ingredient formulations that contain tolperisone) held by SANOCHEMIA PHARMAZEUTIKA AG expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANOCHEMIA PHARMAZEUTIKA AG
Grant date
Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/4453, A61K9/0053, A61K9/20, A61P